vs
RCI HOSPITALITY HOLDINGS, INC.（RICK）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.8倍（$127.1M vs $70.9M），再鼎医药同比增速更快（17.1% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -2.0%）
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
RICK vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.8倍
$70.9M
营收增速更快
ZLAB
高出20.3%
-3.1%
自由现金流更多
RICK
多$38.2M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $70.9M | $127.1M |
| 净利润 | $-5.5M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | -0.7% | -54.6% |
| 净利率 | -7.8% | — |
| 营收同比 | -3.1% | 17.1% |
| 净利润同比 | -2354.9% | — |
| 每股收益（稀释后） | $-0.60 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RICKZLAB
| Q4 25 | — | $127.1M | ||
| Q3 25 | $70.9M | $115.4M | ||
| Q2 25 | $71.1M | $109.1M | ||
| Q1 25 | $65.9M | $105.7M | ||
| Q4 24 | $71.5M | $108.5M | ||
| Q3 24 | $73.2M | $101.8M | ||
| Q2 24 | $76.2M | $100.1M | ||
| Q1 24 | $72.3M | $87.1M |
净利润RICKZLAB
| Q4 25 | — | — | ||
| Q3 25 | $-5.5M | $-36.0M | ||
| Q2 25 | $4.1M | $-40.7M | ||
| Q1 25 | $3.2M | $-48.4M | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $244.0K | $-41.7M | ||
| Q2 24 | $-5.2M | $-80.3M | ||
| Q1 24 | $774.0K | $-53.5M |
毛利率RICKZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率RICKZLAB
| Q4 25 | — | -54.6% | ||
| Q3 25 | -0.7% | -42.3% | ||
| Q2 25 | 12.2% | -50.3% | ||
| Q1 25 | 12.4% | -53.3% | ||
| Q4 24 | 19.5% | -62.6% | ||
| Q3 24 | 4.8% | -66.6% | ||
| Q2 24 | -3.3% | -76.0% | ||
| Q1 24 | 6.4% | -80.7% |
净利率RICKZLAB
| Q4 25 | — | — | ||
| Q3 25 | -7.8% | -31.2% | ||
| Q2 25 | 5.7% | -37.3% | ||
| Q1 25 | 4.9% | -45.8% | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 0.3% | -40.9% | ||
| Q2 24 | -6.9% | -80.2% | ||
| Q1 24 | 1.1% | -61.4% |
每股收益（稀释后）RICKZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-0.60 | $-0.03 | ||
| Q2 25 | $0.46 | $-0.04 | ||
| Q1 25 | $0.36 | $-0.04 | ||
| Q4 24 | $1.01 | $-0.09 | ||
| Q3 24 | $0.04 | $-0.04 | ||
| Q2 24 | $-0.56 | $-0.08 | ||
| Q1 24 | $0.08 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.7M | $689.6M |
| 总债务越低越好 | $238.2M | — |
| 股东权益账面价值 | $261.1M | $715.5M |
| 总资产 | $596.9M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.91× | — |
8季度趋势，按日历期对齐
现金及短期投资RICKZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | $33.7M | $717.2M | ||
| Q2 25 | $29.3M | $732.2M | ||
| Q1 25 | $32.7M | $757.3M | ||
| Q4 24 | $34.7M | $779.7M | ||
| Q3 24 | $32.4M | $616.1M | ||
| Q2 24 | $34.9M | $630.0M | ||
| Q1 24 | $20.0M | $650.8M |
总债务RICKZLAB
| Q4 25 | — | — | ||
| Q3 25 | $238.2M | — | ||
| Q2 25 | $243.8M | — | ||
| Q1 25 | $244.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $241.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RICKZLAB
| Q4 25 | — | $715.5M | ||
| Q3 25 | $261.1M | $759.9M | ||
| Q2 25 | $269.5M | $791.7M | ||
| Q1 25 | $268.8M | $810.8M | ||
| Q4 24 | $269.0M | $840.9M | ||
| Q3 24 | $263.4M | $667.7M | ||
| Q2 24 | $271.2M | $704.2M | ||
| Q1 24 | $285.8M | $762.2M |
总资产RICKZLAB
| Q4 25 | — | $1.2B | ||
| Q3 25 | $596.9M | $1.2B | ||
| Q2 25 | $597.4M | $1.2B | ||
| Q1 25 | $589.8M | $1.2B | ||
| Q4 24 | $586.2M | $1.2B | ||
| Q3 24 | $584.4M | $985.3M | ||
| Q2 24 | $601.0M | $987.4M | ||
| Q1 24 | $609.9M | $988.4M |
负债/权益比RICKZLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.91× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.7M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $11.5M | $-26.7M |
| 自由现金流率自由现金流/营收 | 16.2% | -21.0% |
| 资本支出强度资本支出/营收 | 3.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $34.9M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流RICKZLAB
| Q4 25 | — | $-26.0M | ||
| Q3 25 | $13.7M | $-32.0M | ||
| Q2 25 | $13.8M | $-31.0M | ||
| Q1 25 | $8.5M | $-61.7M | ||
| Q4 24 | $13.3M | $-55.8M | ||
| Q3 24 | $15.7M | $-26.8M | ||
| Q2 24 | $15.8M | $-42.2M | ||
| Q1 24 | $10.8M | $-90.1M |
自由现金流RICKZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | $11.5M | $-35.0M | ||
| Q2 25 | $10.1M | $-33.9M | ||
| Q1 25 | $5.7M | $-63.2M | ||
| Q4 24 | $7.6M | $-58.4M | ||
| Q3 24 | $10.3M | $-28.2M | ||
| Q2 24 | $9.3M | $-42.9M | ||
| Q1 24 | $3.2M | $-91.1M |
自由现金流率RICKZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | 16.2% | -30.4% | ||
| Q2 25 | 14.2% | -31.1% | ||
| Q1 25 | 8.6% | -59.9% | ||
| Q4 24 | 10.6% | -53.8% | ||
| Q3 24 | 14.0% | -27.7% | ||
| Q2 24 | 12.3% | -42.9% | ||
| Q1 24 | 4.4% | -104.5% |
资本支出强度RICKZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | 3.2% | 2.6% | ||
| Q2 25 | 5.2% | 2.6% | ||
| Q1 25 | 4.3% | 1.5% | ||
| Q4 24 | 8.0% | 2.4% | ||
| Q3 24 | 7.3% | 1.3% | ||
| Q2 24 | 8.4% | 0.7% | ||
| Q1 24 | 10.6% | 1.1% |
现金转化率RICKZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.40× | — | ||
| Q1 25 | 2.65× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 64.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 14.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
